The U.S. biotech giant Illumina has been slapped with a $475 million fine for buying cancer-screening company Grail without regulators’ approval, the European Union said…
April 29, 2025
The U.S. biotech giant Illumina has been slapped with a $475 million fine for buying cancer-screening company Grail without regulators’ approval, the European Union said…